Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29)

BACKGROUND AND PURPOSE: We investigated the ability of celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, to modulate expression of ICAM-1 and VCAM-1 in the colon cancer cell line HT29. EXPERIMENTAL APPROACH: We analysed the effect of celecoxib on ICAM-1 and VCAM-1 protein and mRNA expressio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gallicchio, M, Rosa, A C, Dianzani, C, Brucato, L, Benetti, E, Collino, M, Fantozzi, R
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2007
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2267284/
https://ncbi.nlm.nih.gov/pubmed/18084318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0707634
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados